Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Azzak34on Sep 21, 2023 2:01am
163 Views
Post# 35646807

RE:RE:RE:Oh not again...

RE:RE:RE:Oh not again...You spent 2 days coming up with this? Eeugh. 

Let me help you. Drug companies have to achieve a myriad of safety, efficacy and financial targets. When you test drugs to cure or improve illnesses l, like cancer for example, it takes a real long time. Then if you get the design of the trial even slightly wrong you have to basically start again. Complicated business.

I like how you've said "almost zero" haha. Is that more than zero? And did it become almost zero very recently? Did they recently cure a guy of pancreatic cancer? It's all about what's happening now dope. Years ago means nothing when it's all happening now. 

Like, at some point you probably weren't a piece of garbage loser but you are now. You see? 
<< Previous
Bullboard Posts
Next >>